Dynamic Technology Lab’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Dynamic Technology Lab’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,480	Closed	-$204K	–	1517
2023 Q1	$204K	Buy	+5,480	New	+$246K	0.02%	903
2022 Q4	–	Sell	-4,831	Closed	-$337K	–	1624
2022 Q3	$337K	Buy	4,831 +1,554	+47%	+$115K	0.03%	772
2022 Q2	$220K	Sell	3,277 -5,173	-61%	-$329K	0.02%	883
2022 Q1	$695K	Buy	+8,450	New	+$864K	0.08%	444
2021 Q2	–	Sell	-4,108	Closed	-$704K	–	1642
2021 Q1	$704K	Buy	4,108 +2,744	+201%	+$543K	0.08%	394
2020 Q4	$300K	Buy	+1,364	New	+$295K	0.05%	661

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Dynamic Technology Lab's MRTX Position: Q2 2023 in Review

Dynamic Technology Lab sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2023, closing a stake of 5,480 shares — an estimated $204K sold.

Dynamic Technology Lab first reported a position in MRTX in Q4 2020 and held it in 6 quarters. The position peaked at $704K in Q1 2021. 207 funds tracked by Wall St. Rank hold MRTX as of Q2 2023.

Dynamic Technology Lab reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Dynamic Technology Lab sold 5,480 Mirati Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $204K.
Dynamic Technology Lab first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Dynamic Technology Lab's Mirati Therapeutics, Inc. Common Stock position peaked at $704K in Q1 2021.
207 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.